ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGEN Agenus Inc

0.5799
0.0235 (4.22%)
After Hours
Last Updated: 18:16:01
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,511,123
Bid Price 0.5607
Ask Price 0.58
News -
Day High 0.574

Low
0.485

52 Week Range

High
2.13

Day Low 0.5505
Share Name Share Symbol Market Stock Type
Agenus Inc AGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0235 4.22% 0.5799 18:16:01
Open Price Low Price High Price Close Price Previous Close
0.5564 0.5505 0.574 0.58 0.5564
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,819 5,511,123 US$ 0.5643095 US$ 3,109,979 - 0.485 - 2.13
Last Trade Type Quantity Price Currency
18:10:27 1 US$ 0.5602 USD

Agenus Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
238.78M 418.92M - 98.84M -220.29M -0.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Agenus News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AGEN Message Board. Create One! See More Posts on AGEN Message Board See More Message Board Posts

Historical AGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.55160.57970.5250.55186044,968,8430.02835.13%
1 Month0.7360.77630.4850.61727657,953,960-0.1561-21.21%
3 Months0.780.9490.4850.666778910,525,347-0.2001-25.65%
6 Months1.171.170.4850.72708029,814,674-0.5901-50.44%
1 Year1.602.130.4851.007,307,161-1.02-63.76%
3 Years2.886.790.4852.185,431,144-2.30-79.86%
5 Years2.896.790.4852.464,072,272-2.31-79.93%

Agenus Description

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.

Your Recent History

Delayed Upgrade Clock